Vascular Pharmacology

Papers
(The H4-Index of Vascular Pharmacology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Corrigendum to “Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis” [Vascular Pharmacology 155 (2024) 107111
Patterns of medication use and potential drug-drug interactions in post-PCI patients: A study from Iran106
The transfer of gut microbiota/metabolites from children to mice affects cardiometabolic development and induces sex-dimorphism in recipients55
Prevalence of antiphospholipid antibodies in COVID-19 patients: A meta-analysis52
Animal experimental models of ischemic limbs – A systematic review40
Graphical abstract TOC31
Biobanks: The unmet need in heart failure management27
Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study25
Graphical abstract TOC25
Molecular mechanisms of flavonoids in myocardial ischemia reperfusion injury: Evidence from in-vitro and in-vivo studies25
Prevention of cardiovascular complications in elderly cancer patients24
The MEK-ERK-Egr-1 axis and its regulation in cardiovascular disease24
Editorial Board24
Diabetic neuropathy: Molecular approach a treatment opportunity23
Editorial Board23
Changes in arterial myocyte excitability induced by subarachnoid hemorrhage in a rat model21
Diabetes and vascular disease: New therapeutic avenues21
Adipsin in the pathogenesis of cardiovascular diseases20
Indobufen versus aspirin in patients with indication for antiplatelet therapy: A systematic review and meta-analysis19
The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets19
0.96970295906067